|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash and due from banks | ||||||
| Interest-earning deposits | ||||||
| Cash and Cash Equivalents | ||||||
| Securities available for sale, at fair value | ||||||
| Federal Home Loan Bank stock, at cost | ||||||
| Loans receivable, net of allowance for credit losses of $5,251 in 2026 and $4,884 in 2025 | ||||||
| Premises and equipment, net | ||||||
| Accrued interest receivable | ||||||
| Bank-owned life insurance | ||||||
| Other assets | ||||||
| Total Assets | ||||||
| Liabilities and Stockholders' Equity | ||||||
| Liabilities | ||||||
| Deposits: Interest bearing | ||||||
| Deposits: Non-interest bearing | ||||||
| Total Deposits | ||||||
| Long-term debt | ||||||
| Advances from borrowers for taxes and insurance | ||||||
| Other liabilities and accrued interest payable | ||||||
| Total Liabilities | ||||||
| Stockholders' Equity | ||||||
| Preferred stock, $0.01 par value per share, 10,000,000 shares authorized at September 30, 2026 and December 31, 2025; no shares issued or outstanding at September 30, 2026 or December 31, 2025 | ||||||
| Common stock, $0.01 par value per share, 40,000,000 shares authorized at September 30, 2026 and December 31, 2025; 7,779,898 shares issued and outstanding at September 30, 2026, including 84,829 unvested shares, and 7,836,100 shares issued and outstanding at December 31, 2025, including 80,094 unvested shares | ||||||
| Additional paid-in capital | ||||||
| Treasury stock, at cost (1,077,342 shares at June 30, 2025 and 1,101,288 shares at December 31, 2024) | ||||||
| Unearned shares held by ESOP | ||||||
| Unearned shares held by compensation plans | ||||||
| Retained earnings | ||||||
| Accumulated other comprehensive loss | ||||||
| Total Stockholders' Equity | ||||||
| Total Liabilities and Stockholders' Equity |
Loading...